What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for Semaglutide. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
4
Research sources
2
Development entries
2
Latest recorded date
Aug 15, 2025
Latest development activity
Aug 15, 2025 · Approval · Approved · United States
FDA granted accelerated approval for Wegovy injection for noncirrhotic MASH with moderate-to-advanced fibrosis in adults, adding another product-specific semaglutide indication.
Open source ↗Latest research record by publication date
Published 2025 · Regulatory · Regulatory / prescribing information
The FDA prescribing information defines approved indications, contraindications, warnings, adverse reactions, and product-specific clinical evidence for Wegovy.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Approval · Approved · United States
FDA granted accelerated approval for Wegovy injection for noncirrhotic MASH with moderate-to-advanced fibrosis in adults, adding another product-specific semaglutide indication.
Regulatory · Regulatory / prescribing information
The FDA prescribing information defines approved indications, contraindications, warnings, adverse reactions, and product-specific clinical evidence for Wegovy.
Approval · Approved · United States
FDA approved a Wegovy indication to reduce cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight.
Human intervention · Randomized controlled trial
STEP 1 was a large randomized trial that established substantial direct human evidence for semaglutide in chronic weight management.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.